Importantly, Gel KFM loaded with MTX and MET leads to substantial tumor growth inhibition, downregulation of the immune checkpoint protein PD‐L1, and enhanced CD8+ T cell infiltration in vivo. The gene discussed is CD8A; the disease is neoplasm.